• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD8+ T 细胞作为人类皮肤利什曼病 IFN-γ 产生的来源。

CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.

机构信息

Medical Parasitology and Mycology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

PLoS Negl Trop Dis. 2010 Oct 12;4(10):e845. doi: 10.1371/journal.pntd.0000845.

DOI:10.1371/journal.pntd.0000845
PMID:20967288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2953482/
Abstract

BACKGROUND

In human leishmaniasis Th1/Th2 dichotomy similar to murine model is not clearly defined and surrogate marker(s) of protection is not yet known. In this study, Th1/Th2 cytokines (IL-5, IL-10, IL-13 and IFN-γ) profile induced by purified CD4(+)/CD8(+) T cells in response to Leishmania antigens were assessed at transcript and protein levels in 14 volunteers with a history of self-healing cutaneous leishmaniasis (HCL) and compared with 18 healthy control volunteers.

METHODOLOGY/PRINCIPAL FINDINGS: CD4(+)/CD8(+)/CD14(+) cells were purified from peripheral blood using magnetic beads; CD4(+)/CD8(+) T cells were co-cultured with autologous CD14(+) monocytes in the presence of soluble Leishmania antigens (SLA). Stimulation of either CD4(+) T cells or CD8(+) T cells of HCL volunteers with SLA induced a significantly (P<0.05) higher IFN-γ production compared with the cells of controls. Upregulation of IFN-γ gene expression in CD4(+) cells (P<0.001) and CD8(+) cells (P = 0.006) of HCL volunteers was significantly more than that of controls. Significantly (P<0.05) higher fold-expression of IFN-γ gene was seen in CD4(+) cells than in CD8(+) cells. In HCL volunteers a significantly (P = 0.014) higher number of CD4(+) cells were positive for intracellular IFN-γ production than CD8(+) cells.

CONCLUSIONS/SIGNIFICANCE: Collectively, the volunteers have shown maintenance of specific long-term immune responses characterized by a strong reaction to leishmanin skin test and IFN-γ production. The dominant IFN-γ response was the result of expansion of both CD4(+) and CD8(+) T cells. The results suggested that immune response in protected individuals with a history of zoonotic cutaneous leishmaniasis (ZCL) due to L. major is mediated not only through the expansion of antigen-specific IFN-γ producing CD4(+) Th1 cells, but also through IFN-γ producing CD8(+) T cells.

摘要

背景

在人类利什曼病中,类似于鼠类模型的 Th1/Th2 二分法尚不清楚,也尚未确定保护的替代标志物。在这项研究中,我们评估了 14 名有自我治愈皮肤利什曼病(HCL)病史的志愿者和 18 名健康对照志愿者对利什曼抗原产生的纯化 CD4+/CD8+T 细胞诱导的 Th1/Th2 细胞因子(IL-5、IL-10、IL-13 和 IFN-γ)的转录和蛋白水平。

方法/主要发现:使用磁性珠从外周血中纯化 CD4+/CD8+/CD14+细胞;将 CD4+/CD8+T 细胞与自体 CD14+单核细胞在可溶性利什曼抗原(SLA)存在下共培养。与对照组相比,HCL 志愿者的 SLA 刺激 CD4+T 细胞或 CD8+T 细胞诱导 IFN-γ 产生明显升高(P<0.05)。HCL 志愿者 CD4+细胞(P<0.001)和 CD8+细胞(P=0.006)中 IFN-γ 基因表达的上调明显高于对照组。与 CD8+细胞相比,CD4+细胞中 IFN-γ 基因的表达倍数明显升高(P<0.05)。在 HCL 志愿者中,与 CD8+细胞相比,CD4+细胞中 IFN-γ 产生的阳性细胞数量明显更多(P=0.014)。

结论/意义:总之,志愿者表现出维持特定的长期免疫反应,其特征为对利什曼菌素皮肤试验和 IFN-γ 产生的强烈反应。主导的 IFN-γ 反应是 CD4+和 CD8+T 细胞扩张的结果。结果表明,在有动物源性皮肤利什曼病(ZCL)病史的个体中,由于 L. major 引起的免疫反应不仅通过扩张抗原特异性 IFN-γ 产生的 CD4+Th1 细胞来介导,而且还通过 IFN-γ 产生的 CD8+T 细胞来介导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd2/2953482/12d4e01b7250/pntd.0000845.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd2/2953482/ccbb847203cb/pntd.0000845.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd2/2953482/5ec7c1c51c01/pntd.0000845.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd2/2953482/f439456f11eb/pntd.0000845.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd2/2953482/12d4e01b7250/pntd.0000845.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd2/2953482/ccbb847203cb/pntd.0000845.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd2/2953482/5ec7c1c51c01/pntd.0000845.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd2/2953482/f439456f11eb/pntd.0000845.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bd2/2953482/12d4e01b7250/pntd.0000845.g004.jpg

相似文献

1
CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.CD8+ T 细胞作为人类皮肤利什曼病 IFN-γ 产生的来源。
PLoS Negl Trop Dis. 2010 Oct 12;4(10):e845. doi: 10.1371/journal.pntd.0000845.
2
Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.设计包含免疫原性利什曼原虫蛋白的 HLA Ⅰ类和Ⅱ类限制性表位的多表位肽,并评估治愈的皮肤利什曼病患者中诱导的 CD4+和 CD8+ T 细胞反应。
PLoS Negl Trop Dis. 2020 Mar 16;14(3):e0008093. doi: 10.1371/journal.pntd.0008093. eCollection 2020 Mar.
3
Phenotypic and Functional Profiles of Antigen-Specific CD4 and CD8 T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis.与皮肤利什曼病患者感染控制相关的抗原特异性 CD4 和 CD8 T 细胞的表型和功能特征。
Front Cell Infect Microbiol. 2018 Nov 19;8:393. doi: 10.3389/fcimb.2018.00393. eCollection 2018.
4
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.流式细胞术测定人类皮肤利什曼病中针对重组LACK和可溶性利什曼原虫抗原的关键细胞因子产生淋巴细胞的细胞来源和频率。
Infect Immun. 2001 May;69(5):3232-9. doi: 10.1128/IAI.69.5.3232-3239.2001.
5
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.美洲皮肤利什曼病患者对纯化的皮氏利什曼原虫无鞭毛体抗原和巴西利什曼原虫前鞭毛体抗原的T细胞反应性:与治愈相关的免疫模式
Exp Parasitol. 1996 Nov;84(2):144-55. doi: 10.1006/expr.1996.0100.
6
Differential in vitro CD4+/CD8+ T-cell response to live vs. killed Leishmania major.活的 vs. 死的利什曼原虫体外 CD4+/CD8+ T 细胞反应的差异。
Parasite Immunol. 2010 Feb;32(2):101-10. doi: 10.1111/j.1365-3024.2009.01164.x.
7
Acute IL-4 Governs Pathogenic T Cell Responses during Infection.急性 IL-4 调控 感染期间的致病 T 细胞反应。
Immunohorizons. 2020 Sep 18;4(9):546-560. doi: 10.4049/immunohorizons.2000076.
8
CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis.人类皮肤利什曼病中 CCR7+ 中央和 CCR7- 效应记忆 CD4+ T 细胞。
J Clin Immunol. 2013 Jan;33(1):220-34. doi: 10.1007/s10875-012-9788-7. Epub 2012 Sep 19.
9
CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis.皮肤利什曼病患者CD4+T细胞上CD26的表达
Clin Exp Immunol. 2008 Jul;153(1):31-6. doi: 10.1111/j.1365-2249.2008.03666.x. Epub 2008 May 5.
10
Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8 T Cells Are Associated With the Cure of Human Visceral sis.多功能、分泌 TNF-α 和 IFN-γ 的 CD4 和 CD8 T 细胞及 CD8 T 细胞与人类内脏利什曼病的治愈有关。
Front Immunol. 2021 Oct 28;12:773983. doi: 10.3389/fimmu.2021.773983. eCollection 2021.

引用本文的文献

1
CRISPR/Cas9-mediated deletion of a kinetoplast-associated gene attenuates virulence in Leishmania major parasites.CRISPR/Cas9介导的动基体相关基因缺失减弱了杜氏利什曼原虫的毒力。
Med Microbiol Immunol. 2025 Mar 25;214(1):16. doi: 10.1007/s00430-025-00827-1.
2
Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis.记忆T细胞:评估抗利什曼病保护作用和疫苗效力的有前景的生物标志物。
Front Immunol. 2024 Feb 26;15:1304696. doi: 10.3389/fimmu.2024.1304696. eCollection 2024.
3
A Prospective cohort study of zoonotic cutaneous leishmaniasis in tunisia: Clinical and Immunological features and immune correlates of protection.

本文引用的文献

1
Immune response of BALB/c mice against an experimental vaccine of Alum precipitated autoclaved Leishmania major (Alum-ALM) mixed with BCG or Mycobacterium vaccae.BALB/c小鼠对与卡介苗或母牛分枝杆菌混合的明矾沉淀高压灭菌的硕大利什曼原虫(Alum-ALM)实验疫苗的免疫反应。
Trop Biomed. 2010 Apr;27(1):89-102.
2
Differential in vitro CD4+/CD8+ T-cell response to live vs. killed Leishmania major.活的 vs. 死的利什曼原虫体外 CD4+/CD8+ T 细胞反应的差异。
Parasite Immunol. 2010 Feb;32(2):101-10. doi: 10.1111/j.1365-3024.2009.01164.x.
3
Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis.
一项关于突尼斯动物源性皮肤利什曼病的前瞻性队列研究:临床和免疫学特征以及保护的免疫相关性。
PLoS Negl Trop Dis. 2023 Dec 8;17(12):e0011784. doi: 10.1371/journal.pntd.0011784. eCollection 2023 Dec.
4
The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study.伊朗患者中人类白细胞抗原(HLA)I类和II类基因与皮肤利什曼病和内脏利什曼病的关联:一项初步病例对照研究
Iran J Parasitol. 2023 Apr-Jun;18(2):155-164. doi: 10.18502/ijpa.v18i2.13181.
5
Deletion of MIF gene from live attenuated LdCen parasites enhances protective CD4 T cell immunity.从减毒的 LdCen 寄生虫中删除 MIF 基因可增强保护性 CD4 T 细胞免疫。
Sci Rep. 2023 May 5;13(1):7362. doi: 10.1038/s41598-023-34333-2.
6
Evaluation of expression variations in virulence-related genes of Leishmania major after several culture passages compared with Phlebotomus papatasi isolated promastigotes.评价与从埃及伊蚊中分离的前鞭毛体相比,经过多次培养传代后,利什曼原虫主要毒力相关基因的表达变化。
PLoS One. 2023 Apr 13;18(4):e0284240. doi: 10.1371/journal.pone.0284240. eCollection 2023.
7
Immunopathology of Cutaneous Leishmaniasis in a Cohort of Sri Lankan Patients.一组斯里兰卡患者皮肤利什曼病的免疫病理学
Clin Pathol. 2022 Nov 2;15:2632010X221134804. doi: 10.1177/2632010X221134804. eCollection 2022 Jan-Dec.
8
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial.与此前接种过两剂科兴疫苗的志愿者相比,皮内注射三分之一剂量 ChAdOx1 nCoV-19/阿斯利康腺病毒疫苗与标准肌肉注射三分之一剂量相比的免疫原性和安全性:一项随机对照试验。
Vaccine. 2022 Mar 15;40(12):1761-1767. doi: 10.1016/j.vaccine.2022.02.019. Epub 2022 Feb 21.
9
Upregulation of , , and efflux pump genes associated with resistance of strains to disinfectants.与肺炎克雷伯菌菌株对消毒剂耐药性相关的、、和外排泵基因的上调。 (你提供的原文中基因名称处有缺失内容,我按照完整格式进行了翻译补充,请根据实际情况核对)
Health Sci Rep. 2021 Oct 1;4(4):e395. doi: 10.1002/hsr2.395. eCollection 2021 Dec.
10
Immune Responses in Cutaneous Leishmaniasis: Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed .皮肤利什曼病中的免疫反应:使用活疫苗与灭活疫苗的辅助性T细胞1/辅助性T细胞2细胞因子谱
J Arthropod Borne Dis. 2021 Mar 31;15(1):126-135. doi: 10.18502/jad.v15i1.6491. eCollection 2021 Mar.
表达颗粒酶A的CD8(+) T细胞的募集与人类皮肤利什曼病的病变进展相关。
Parasite Immunol. 2009 Aug;31(8):432-9. doi: 10.1111/j.1365-3024.2009.01125.x.
4
Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis.灭活全寄生虫疫苗在预防利什曼病中的疗效:一项荟萃分析。
Vaccine. 2009 Jul 30;27(35):4747-53. doi: 10.1016/j.vaccine.2009.05.084. Epub 2009 Jun 18.
5
Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.Th1/Th2免疫反应与活动性皮肤利什曼病相关,而临床治愈与强烈的γ干扰素产生相关。
Hum Immunol. 2009 Jun;70(6):383-90. doi: 10.1016/j.humimm.2009.01.007. Epub 2009 Jan 20.
6
Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment.美国皮肤利什曼病患者化疗治疗前后的细胞免疫反应概况。
J Clin Lab Anal. 2009;23(1):63-9. doi: 10.1002/jcla.20291.
7
Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.伯氏疟原虫感染血液阶段期间CD8 + T细胞的疟疾特异性和非特异性激活。
J Immunol. 2008 Jul 15;181(2):1420-8. doi: 10.4049/jimmunol.181.2.1420.
8
Kinetoplastids: related protozoan pathogens, different diseases.动质体目:相关的原生动物病原体,引发不同疾病。
J Clin Invest. 2008 Apr;118(4):1301-10. doi: 10.1172/JCI33945.
9
CD8 cytotoxic T cells in cutaneous leishmaniasis.皮肤利什曼病中的CD8细胞毒性T细胞。
Parasite Immunol. 2007 Dec;29(12):671-8. doi: 10.1111/j.1365-3024.2007.00991.x.
10
Cellular analysis of cutaneous leishmaniasis lymphadenopathy: insights into the early phases of human disease.皮肤利什曼病淋巴结病的细胞分析:对人类疾病早期阶段的见解
Am J Trop Med Hyg. 2007 Nov;77(5):854-9.